Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke.

J Oncol · 2015 · PMC4439482 · PMID 26064116

Europe PMC DOI

hedged sentence

0.2490

closest p · 5.0× alpha

0.2490

boldest claim

The sentences

did not reach statistical significancep = 0.249not close (p > 0.1)

However, the difference in stroke recurrence between the two groups did not reach statistical significance primarily due to small sample size ( p = 0.249 by the log-rank test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.